Impact of early treatment with intravenous vasodilators and blood pressure reduction in acute heart failure

OBJECTIVE: Although vasodilators are used in acute heart failure (AHF) management, there have been no clear supportive evidence regarding their routine use. Recent European guidelines recommend systolic blood pressure (SBP) reduction in the range of 25% during the first few hours after diagnosis. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Kitai, Takeshi, Tang, W H Wilson, Xanthopoulos, Andrew, Murai, Ryosuke, Yamane, Takafumi, Kim, Kitae, Oishi, Shogo, Akiyama, Eiichi, Suzuki, Satoshi, Yamamoto, Masayoshi, Kida, Keisuke, Okumura, Takahiro, Kaji, Shuichiro, Furukawa, Yutaka, Matsue, Yuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Heart Failure and Cardiomyopathies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045748/
https://www.ncbi.nlm.nih.gov/pubmed/30018782
http://dx.doi.org/10.1136/openhrt-2018-000845

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045748/
https://www.ncbi.nlm.nih.gov/pubmed/30018782
http://dx.doi.org/10.1136/openhrt-2018-000845

Ejemplares similares